Interleukin-1 β gene polymorphisms in Egyptian patients with rheumatoid arthritis

被引:4
作者
Darwish R.K. [1 ]
Ramadan D.I. [1 ]
Mohy A.M. [1 ]
Raafat H.A. [2 ]
Abou Youssef H.E.-S. [1 ]
El-Kateb S.M. [1 ]
机构
[1] Clinical and Chemical Pathology Department, Cairo University, Cairo, Manial
[2] Rheumatology and Rehabilitation Department, Cairo University, Cairo, Manial
关键词
Gene polymorphism; IL-1β; -511; promoter; PCR-RFLP; Rheumatoid arthritis;
D O I
10.1007/s00580-012-1672-6
中图分类号
学科分类号
摘要
The present study aimed at evaluating the role of IL-1β -511 promoter and IL-1β +3953 exon 5 gene polymorphisms in the risk of developing rheumatoid arthritis (RA) and its correlation to disease activity in Egyptian patients. Thirty-two patients having RA as defined by American College of Rheumatology and 20 healthy control subjects were included. All were subjected to DNA analysis for IL-1β -511and IL-1β +3953 gene polymorphisms using PCR-RFLP technique with restriction enzymes AvaI and TaqI, respectively. No special pattern of association could be detected either between IL-1β -511 and +3953 gene polymorphisms and disease susceptibility or between the polymorphisms and the disease activity parameters represented by disease activity score 28 (DAS 28), ESR, and number of swollen and tender joints. Allele distribution failed as well to detect any association with either disease susceptibility or activity; however, a trend towards positive association involving IL-1β -511 C allele was observed (P = 0.054). Our results suggest that IL-1β -511 and IL-1β +3953 gene polymorphisms do not influence the susceptibility to acquire RA in our population with no relation to disease activity. The complex role of the genetic factors in RA and the magnitude of the effects will require further thorough confirmations in other populations and on larger samples to acknowledge this issue. © 2013 Springer-Verlag London.
引用
收藏
页码:689 / 694
页数:5
相关论文
共 20 条
[1]  
Arman A., Yilmaz B., Coker A., Inanc N., Direskeneli H., Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis, Clin Exp Rheumatol, 24, pp. 643-648, (2006)
[2]  
Arned W.P., Dayer J.M., Inhibition of the production and effects of interleukin -1 and tumor necrosis factor alpha in rheumatoid arthritis, Arthritis Rheumatol, 38, pp. 151-160, (1995)
[3]  
Arnett F.C., Edworthy S.M., Bloch D.A., Mcshane D.J., Fries J.F., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheumatol, 31, pp. 315-324, (1988)
[4]  
Brennan F.M., McInnes B., Evidence that cytokines play a role in rheumatoid arthritis, J Clin Invest, 11, pp. 3537-3545, (2008)
[5]  
Camargo J.F., Correa P.A., Castiblanco J., Anaya J.M., Interleukin-1 beta polymorphism in Colombian patients with autoimmune rheumatic disease, Genes Immun, 5, pp. 609-614, (2004)
[6]  
Choy E.H., Panayi G.S., Cytokine pathways and joint inflammation in rheumatoid arthritis, N Engel J Med, 344, pp. 907-916, (2001)
[7]  
Cutolo M., IL-1Ra: its role in rheumatoid arthritis, Reumatismo, 56, pp. 41-45, (2004)
[8]  
Genevay S., Di Giovine F.S., Perneger T.V., Silvestri S., Stingelin S., Duff G., Association of IL-4 and IL-1B gene variants with Larsen score progression in rheumatoid arthritis, Arthritis Rheum, 47, pp. 303-319, (2002)
[9]  
Havemose-Poulsen A., Sorensen L.K., Bendtzen K., Holmstrup P., Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis, J Periodontol, 78, pp. 475-492, (2007)
[10]  
John S., Worthington J., Genetic epidemiology: approaches to the genetic analysis of rheumatoid arthritis, Arthritis Res, 3, pp. 216-220, (2001)